Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors

Anaplastic lymphoma kinase (ALK) has been recognised as a promising molecular target of targeted therapy for NSCLC. We performed SAR study of pyrazolo[3,4-b]pyridines to override crizotinib resistance caused by ALK-L1196M mutation and identified a novel and potent L1196M inhibitor, 10g. 10g displaye...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Yunju, Hwang, Dongkeun, Kim, Namdoo, Seo, Hong-Seog, Selim, Khalid B., Sim, Taebo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713165/
https://www.ncbi.nlm.nih.gov/pubmed/31401883
http://dx.doi.org/10.1080/14756366.2019.1639694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713165/
https://www.ncbi.nlm.nih.gov/pubmed/31401883
http://dx.doi.org/10.1080/14756366.2019.1639694

Ejemplares similares